Ark Adds SpaceX, Circle to ARKK Top 10 After Buys

Ark Invest placed SpaceX and Circle among ARKK’s top 10 holdings after buying 181,830 SpaceX shares (~$20M) and 273,343 Circle shares (~$17.3M) following Q2 reports.

Ark Invest added SpaceX and Circle to the top 10 holdings of the Ark Innovation ETF (ARKK) after purchases disclosed Thursday. The firm bought 181,830 SpaceX shares, about $20 million, across four Ark ETFs and 273,343 Circle shares, about $17.3 million, across ARKK and two other Ark funds.

The filing shows SpaceX is ARKK’s fifth-largest holding with a market value near $282 million and a 4.73% portfolio weighting. Circle is the eighth-largest holding at roughly $233 million, representing 3.90% of the fund.

Ark’s trading activity followed second-quarter reports from both companies. Circle reported $701 million in second-quarter revenue and reserve income, up 7% year over year, and adjusted EBITDA of $143 million, up 8%. USDC circulation rose to $73.3 billion, up 19%, while on-chain transaction volume increased 151% to $14.8 trillion. Circle shares were little changed after the results.

SpaceX reported quarterly revenue of $7.8 billion, a 92% increase from a year earlier, and disclosed $18.4 billion in planned capital expenditures to expand its artificial intelligence capabilities. SpaceX shares fell 13.6% on the quarter.

In late July Ark rebalanced several crypto-related holdings, selling shares of Bitmine, Robinhood, Block and Bullish while buying about $43.5 million of Coinbase and Circle stock and roughly $14.5 million of SpaceX shares. The firm continued adding positions across its actively managed ETFs in recent filings.

Other large positions in ARKK include Tesla, Coinbase, Robinhood, OpenAI, Bitmine and Palantir.

The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.

Articles by this author